v3.26.3
FAIR VALUE (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present the assets and liabilities that are measured at fair value on a recurring and nonrecurring basis by major product category and fair value hierarchy as of the dates indicated:
(in millions)Level 1Level 2Level 3
Balance at
September 30, 2026
Level 1Level 2Level 3
Balance at December 31, 2025
Recurring:
Financial assets:
U.S. Treasury securities$226 $— $— $226 $706 $— $— $706 
Corporate debt— 9 — 9 — — — — 
ABS— 2,037 — 2,037 — 945 — 945 
Beneficial interest in Structured LLC
— — 1,013 1,013 — — 1,097 1,097 
MBS— 6,378 — 6,378 — 4,580 — 4,580 
Investment in debt securities AFS (2)
$226 $8,424 $1,013 $9,663 $706 $5,525 $1,097 $7,328 
Trading securities2,851 14,870 112 17,833 3,539 11,897 173 15,609 
Equity securities41 — 890 931 — — 992 992 
RICs HFI (3)
— — 3 3 — — 5 5 
LHFS (1)(4)
— 1,685 — 1,685 — 1,531 — 1,531 
MSRs— — 83 83 — — 80 80 
Other assets - derivatives (2)
1 1,740 — 1,741 1 671 — 672 
Total financial assets (5)
$3,119 $26,719 $2,101 $31,939 $4,246 $19,624 $2,347 $26,217 
Financial liabilities:
Trading liabilities3,848 177 — 4,025 3,728 274 — 4,002 
Other liabilities - derivatives (2)
— 1,529 1 1,530 — 648 1 649 
Total financial liabilities$3,848 $1,706 $1 $5,555 $3,728 $922 $1 $4,651 
Nonrecurring:
Financial assets:
Impaired commercial LHFI$— $361 $454 $815 $— $213 $3 $216 
Foreclosed assets— 28 — 28 — 32 — 32 
Vehicle inventory— 371 — 371 — 379 — 379 
LHFS— — 288 288 — — 55 55 
Auto loans impaired due to bankruptcy— 171 — 171 — 168 — 168 
Total financial assets valued at fair value on a non-recurring basis$— $931 $742 $1,673 $— $792 $58 $850 
(1)    LHFS disclosed on the Condensed Consolidated Balance Sheets also includes LHFS that are held at the lower of cost or fair value and are presented within the nonrecurring section of this table.
(2)    Refer to Note 2 for the fair value of investment securities and to Note 13 for the fair values of derivative assets and liabilities on a further disaggregated basis.
(3) Certain RICs collateralized by vehicle titles and RV/marine loans.
(4) Residential mortgage loans and commercial mortgage loans.
(5) Approximately $2.1 billion of these financial assets were measured using model-based techniques, or Level 3 inputs, and represented approximately 6.6% of total assets measured at fair value on a recurring basis and approximately 0.8% of total consolidated assets.
Schedule of Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The tables below present the changes in Level 3 balances for those assets and liabilities measured at fair value on a recurring basis for the periods indicated.
Three months ended September 30, 2026
Three months ended September 30, 2025
(in millions)Beneficial Interest in Structured LLCRICs HFIMSRsDerivatives, netEquity SecuritiesTrading SecuritiesTotalBeneficial interest in Structured LLCRICs HFIMSRsDerivatives, netEquity SecuritiesTrading SecuritiesTotal
Balances, beginning of period$1,056 $3 $79 $(1)$928 $111 $2,176 $1,118 $7 $82 $— $— $156 $1,363 
Gains / (losses) in OCI(43)— — — — — (43)(10)— — — — — (10)
Gains/(losses) in earnings— — 6 — (3)4 7 — — 2 (1)— (6)(5)
Additions/Issuances— — 1 — — 1 2 — — — — 832 10 842 
Transfers from Level 2— — — — — 6 6 — — — — — 68 68 
Transfers from Level 3— — — — (41)— (41)— — — — — — — 
Settlements(1)
— — (3)— 6 (10)(7)(10)(1)(3)— — (22)(36)
Balances, end of period$1,013 $3 $83 $(1)$890 $112 $2,100 $1,098 $6 $81 $(1)$832 $206 $2,222 
Changes in unrealized gains (losses) included in earnings related to balances still held at end of period$— $— $6 $— $(23)$4 $(13)$— $— $2 $(1)$— $(6)$(5)
Nine months ended September 30, 2026
Nine months ended September 30, 2025
(in millions)Beneficial Interest in Structured, LLCRICs HFIMSRsDerivatives, netEquity SecuritiesTrading SecuritiesTotalBeneficial interest in Structured, LLCRICs HFIMSRsDerivatives, netEquity SecuritiesTrading SecuritiesTotal
Balances, beginning of period$1,097 $5 $80 $(1)$992 $173 $2,346 $1,199 $9 $91 $— $— $6 $1,305 
Gain / (losses) in OCI(56)— — — — — (56)(81)— — — — — (81)
Gains/(losses) in earnings— — 10 — (20)2 (8)— — (3)(1)— (6)(10)
Additions/Issuances— — 1 — — 6 7 — — — — 832 10 842 
Transfers from Level 2— — — — — 6 6 — — — — — 220 220 
Transfers from Level 3— — — — (41)— (41)— — — — — — — 
Settlements (1)
(28)(2)(8)— (41)(75)(154)(20)(3)(7)— — (24)(54)
Balances, end of period$1,013 $3 $83 $(1)$890 $112 $2,100 $1,098 $6 $81 $(1)$832 $206 $2,222 
Changes in unrealized gains (losses) included in earnings related to balances still held at end of period$— $— $10 $— $(58)$2 $(46)$— $— $(3)$(1)$— $(6)$(10)
(1)Settlements include charge-offs, prepayments, paydowns, sales, and maturities.
Schedule of Assets Measured at Fair Value on a Nonrecurring Basis
The following tables present the assets and liabilities that are measured at fair value on a recurring and nonrecurring basis by major product category and fair value hierarchy as of the dates indicated:
(in millions)Level 1Level 2Level 3
Balance at
September 30, 2026
Level 1Level 2Level 3
Balance at December 31, 2025
Recurring:
Financial assets:
U.S. Treasury securities$226 $— $— $226 $706 $— $— $706 
Corporate debt— 9 — 9 — — — — 
ABS— 2,037 — 2,037 — 945 — 945 
Beneficial interest in Structured LLC
— — 1,013 1,013 — — 1,097 1,097 
MBS— 6,378 — 6,378 — 4,580 — 4,580 
Investment in debt securities AFS (2)
$226 $8,424 $1,013 $9,663 $706 $5,525 $1,097 $7,328 
Trading securities2,851 14,870 112 17,833 3,539 11,897 173 15,609 
Equity securities41 — 890 931 — — 992 992 
RICs HFI (3)
— — 3 3 — — 5 5 
LHFS (1)(4)
— 1,685 — 1,685 — 1,531 — 1,531 
MSRs— — 83 83 — — 80 80 
Other assets - derivatives (2)
1 1,740 — 1,741 1 671 — 672 
Total financial assets (5)
$3,119 $26,719 $2,101 $31,939 $4,246 $19,624 $2,347 $26,217 
Financial liabilities:
Trading liabilities3,848 177 — 4,025 3,728 274 — 4,002 
Other liabilities - derivatives (2)
— 1,529 1 1,530 — 648 1 649 
Total financial liabilities$3,848 $1,706 $1 $5,555 $3,728 $922 $1 $4,651 
Nonrecurring:
Financial assets:
Impaired commercial LHFI$— $361 $454 $815 $— $213 $3 $216 
Foreclosed assets— 28 — 28 — 32 — 32 
Vehicle inventory— 371 — 371 — 379 — 379 
LHFS— — 288 288 — — 55 55 
Auto loans impaired due to bankruptcy— 171 — 171 — 168 — 168 
Total financial assets valued at fair value on a non-recurring basis$— $931 $742 $1,673 $— $792 $58 $850 
(1)    LHFS disclosed on the Condensed Consolidated Balance Sheets also includes LHFS that are held at the lower of cost or fair value and are presented within the nonrecurring section of this table.
(2)    Refer to Note 2 for the fair value of investment securities and to Note 13 for the fair values of derivative assets and liabilities on a further disaggregated basis.
(3) Certain RICs collateralized by vehicle titles and RV/marine loans.
(4) Residential mortgage loans and commercial mortgage loans.
(5) Approximately $2.1 billion of these financial assets were measured using model-based techniques, or Level 3 inputs, and represented approximately 6.6% of total assets measured at fair value on a recurring basis and approximately 0.8% of total consolidated assets.
Schedule of Increases and Decreases in Value of Certain Assets Measured at Fair Value on Nonrecurring Basis
The following table presents the increases and decreases in value of certain assets that are measured at fair value on a nonrecurring basis for which a fair value adjustment has been included in the Condensed Consolidated Statements of Operations relating to assets held at period-end:
Three months ended September 30,
Nine months ended September 30,
(in millions)Statement of Operations Location202620252026
2025
Impaired LHFICredit loss expense / (benefit)$23 $(8)$38 $(9)
Foreclosed assets
Miscellaneous income, net (1)
— — 4 (11)
LHFSCredit loss expense / (benefit)(2)— (2)9 
LHFS
Miscellaneous income, net (1)
— — (4)— 
Auto loans impaired due to bankruptcyCredit loss expense / (benefit)(8)— (7)4 
(1)    Gains are disclosed as positive numbers while losses are shown as a negative number regardless of the line item being affected.
Schedule of Quantitative Information on Level 3 Recurring Assets and Liabilities
The following table presents quantitative information about the significant unobservable inputs within significant Level 3 recurring and nonrecurring assets and liabilities at the dates indicated:
(dollars in millions)
Fair Value at
September 30, 2026 (4)
Valuation TechniqueUnobservable InputsRange
(Weighted Average)
Financial Assets:
Beneficial interest in Structured LLC$1,013 DCFDiscount spread
2.75% - 25.00% (14.35%)
Loss estimate
0.00% - 42.64% (6.55%)
Extension of loan(1)
48 months or 60 months
Equity securities890 Market comparable pricingLiquidity discount
0.00% - 25.00% (24.00%)
Multiples of revenue
0.8x - 17.9x (6.8x)
MSRs83 DCF
CPR (2)
  6.53% - 37.07% (6.94%)
Discount rate (3)
9.22 %
(1)    Includes extensions related to workouts and contractual extensions.
(2)     Average CPR projected from collateral stratified by loan type and note rate. Weighted average amount was developed by weighting the associated relative UPB.
(3)    Average discount rate from collateral stratified by loan type and note rate. Weighted average amount was developed by weighting the associated relative UPB.
(4) Excluded insignificant Level 3 assets and liabilities.
NOTE 14. FAIR VALUE (continued)

(dollars in millions)
Fair Value at December 31, 2025 (4)
Valuation TechniqueUnobservable InputsRange
(Weighted Average)
Financial Assets:
Beneficial interest in Structured LLC$1,097 
DCF
Discount spread
2.75% - 25.00% (13.78%)
Loss estimate
0.00% - 81.33% (6.85%)
Extension of loan (1)
48 or 60 months
Equity securities$992 Market comparable pricingLiquidity discount
0.00% - 25.00% (24.00%)
Multiples of revenue
0.8x - 17.9x (3.8x)
MSRs$80 DCF
CPR (2)
6.48% - 39.82% (7.07%)
Discount rate (3)
9.22 %
(1), (2), (3), (4) - See corresponding footnotes to the September 30, 2026 Level 3 significant inputs table above.
Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments
The carrying amounts and estimated fair values, as well as the level within the fair value hierarchy, of the Company's financial instruments which have not previously been disclosed above are as follows as of the dates indicated:
September 30, 2026December 31, 2025
(dollars in millions)Carrying ValueFair ValueLevel 1Level 2Level 3Carrying ValueFair ValueLevel 1Level 2Level 3
Financial assets:
Cash, cash equivalents, and restricted cash$30,230 $30,230 $30,230 $— $— $19,696 $19,696 $19,696 $— $— 
Federal funds sold and securities purchased under resale agreements or similar arrangements9,592 9,572 — 9,572 — 8,640 8,641 — 8,641 — 
Investments in debt securities HTM22,584 20,732 1,771 18,961 — 13,212 11,871 2,087 9,784 — 
Equity and other investments (2)
936 936 41 5 890 997 997 — 5 992 
LHFI, net (3)
135,058 137,215 — 532 136,683 76,891 77,028 — 382 76,646 
Financial liabilities:
Deposits (1)
21,032 21,002 — 21,002 — 15,077 15,095 — 15,095 — 
Federal funds purchased and securities loaned or sold under repurchase agreements22,790 22,772 — 22,772 — 19,460 19,463 — 19,463 — 
Borrowings and other debt obligations42,816 42,790 — 42,408 382 37,102 37,747 — 34,364 3,383 
(1) This line item excludes deposit liabilities with no defined or contractual maturities.
(2) This line item includes CDs with a maturity greater than 90 days and equity securities.
(3) This line item includes nonrecurring LHFI.
Schedule of Difference Between Fair Value and Principal Balance of LHFS
The following table summarizes the differences between the fair value and the principal balance of financial instruments measured at fair value on a recurring basis as of the dates indicated:
September 30, 2026December 31, 2025
(in millions)Fair ValuePrincipal BalanceDifferenceFair ValuePrincipal BalanceDifference
LHFS(1)
$1,685 $1,668 $17 $1,531 $1,484 $47 
RICs HFI3 3 — 5 5 — 
(1) LHFS disclosed on the Condensed Consolidated Balance Sheets also includes $288 million and $55 million of LHFS valued on a non-recurring basis at September 30, 2026 and December 31, 2025, respectively, that are held at the lower of cost or fair value that are not presented within this table. There were no nonaccrual loans related to the LHFS measured using the FVO.